| 2021 | | Anti-osteoporotic effect of morroniside on osteoblast and osteoclast differentiation in vitro and ovariectomized mice in vivo | 김정현, 박은국, 이창근, 정선용 |
| 2019 | | Anti-Osteoporotic Effects of Combined Extract of Lycii Radicis Cortex and Achyranthes japonica in Osteoblast and Osteoclast Cells and Ovariectomized Mice | 김정현, 박은국, 정선용 |
| 2019 | | Anti-Osteoporotic Effects of Kukoamine B Isolated from Lycii Radicis Cortex Extract on Osteoblast and Osteoclast Cells and Ovariectomized Osteoporosis Model Mice | 김정현, 박은국, 정선용 |
| 2016 | | Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension | 정윤석 |
| 2014 | | Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study. | 원예연 |
| 2024 | | Cancer treatment-induced bone loss | 최용준 |
| 2020 | | Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis | 박래웅 |
| 2020 | | Computed tomography imaging features of osteomyelitis of the jaw: comparison between antiresorptive medication-related conditions and medication-unrelated conditions | 신정원 |
| 2015 | | Does Zoledronate Prevent Femoral Head Collapse from Osteonecrosis? A Prospective, Randomized, Open-Label, Multicenter Study. | 원예연 |
| 2019 | | Dual-energy X-ray Absorptiometry Monitoring with Trabecular Bone Score: 2019 ISCD Official Position | 정윤석 |
| 2013 | | Early changes in 25-hydroxyvitamin D levels and bone markers after monthly risedronate with cholecalciferol in Korean patients with osteoporosis. | 정윤석 |
| 2011 | | Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome. | 김옥화 |
| 2006 | | Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. | 김대중, 정윤석 |
| 2011 | | Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis. | 정윤석 |
| 2019 | | Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis | 원예연 |
| 2010 | | Genetic polymorphism of geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women. | 정윤석 |
| 2024 | | Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw | 신정원 |
| 2021 | | Romosozumab in postmenopausal Korean women with osteoporosis: A randomized, double-blind, placebo-controlled efficacy and safety study | 정윤석 |
| 2019 | | Safety of bazedoxifene in Korean women with post-menopausal osteoporosis: a post-marketing surveillance study (PMSS) | 정윤석 |
| 2021 | | Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report | 김정택 |
| 2016 | | Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis | 정윤석 |
